For research use only. Not for therapeutic Use.
RBN013209 is a potent CD38 inhibitor with an IC50 of 0.01-0.1 μM for human CD38. RBN013209 can be used for the research of of cancer[1].
| Catalog Number | I043865 |
| CAS Number | 2597933-17-8 |
| Synonyms | 2-imidazol-1-yl-N-[4-(2-methoxyethoxy)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide |
| Molecular Formula | C19H24N6O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C19H24N6O3/c1-27-10-11-28-14-4-2-13(3-5-14)22-18(26)17-16-15(6-7-21-16)23-19(24-17)25-9-8-20-12-25/h6-9,12-14,21H,2-5,10-11H2,1H3,(H,22,26) |
| InChIKey | VQRPLBOIYMUPNF-UHFFFAOYSA-N |
| SMILES | COCCOC1CCC(CC1)NC(=O)C2=NC(=NC3=C2NC=C3)N4C=CN=C4 |
| Reference | [1]. Laurie B. Schenkel, et al. Heterobicyclic amides as inhibitors of cd38. WO2021021986A1. |
